Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Role of prostate specific antigen and immediate confirmatory biopsy in predicting progression during active surveillance for low risk prostate cancer.

Adamy A, Yee DS, Matsushita K, Maschino A, Cronin A, Vickers A, Guillonneau B, Scardino PT, Eastham JA.

J Urol. 2011 Feb;185(2):477-82. doi: 10.1016/j.juro.2010.09.095. Epub 2010 Dec 17.

2.

Active surveillance for prostate cancer: when to recommend delayed intervention.

Babaian KN.

Asian J Androl. 2015 Nov-Dec;17(6):885-7; discussion 886-7. doi: 10.4103/1008-682X.151396. Review.

3.

Active surveillance for favorable-risk prostate cancer: background, patient selection, triggers for intervention, and outcomes.

Klotz L.

Curr Urol Rep. 2012 Apr;13(2):153-9. doi: 10.1007/s11934-012-0242-4. Review.

PMID:
22477615
4.

Systematic Review and Meta-analysis of Factors Determining Change to Radical Treatment in Active Surveillance for Localized Prostate Cancer.

Simpkin AJ, Tilling K, Martin RM, Lane JA, Hamdy FC, Holmberg L, Neal DE, Metcalfe C, Donovan JL.

Eur Urol. 2015 Jun;67(6):993-1005. doi: 10.1016/j.eururo.2015.01.004. Epub 2015 Jan 21. Review.

PMID:
25616709
5.

Active surveillance for prostate cancer.

Romero-Otero J, García-Gómez B, Duarte-Ojeda JM, Rodríguez-Antolín A, Vilaseca A, Carlsson SV, Touijer KA.

Int J Urol. 2016 Mar;23(3):211-8. doi: 10.1111/iju.13016. Epub 2015 Nov 30. Review.

6.

Novel tools to improve patient selection and monitoring on active surveillance for low-risk prostate cancer: a systematic review.

van den Bergh RC, Ahmed HU, Bangma CH, Cooperberg MR, Villers A, Parker CC.

Eur Urol. 2014 Jun;65(6):1023-31. doi: 10.1016/j.eururo.2014.01.027. Epub 2014 Jan 28. Review.

PMID:
24491309
7.

Active surveillance monitoring: the role of novel biomarkers and imaging.

Ward JF, Eggener SE.

Asian J Androl. 2015 Nov-Dec;17(6):882-4; discussion 883. doi: 10.4103/1008-682X.156858. Review.

8.

[Active surveillance for prostate cancer].

Graefen M, Ahyai S, Heuer R, Salomon G, Schlomm T, Isbarn H, Budäus L, Heinzer H, Huland H.

Urologe A. 2008 Mar;47(3):261-9. doi: 10.1007/s00120-008-1638-0. Review. German.

PMID:
18273597
9.

National Institutes of Health State-of-the-Science Conference: role of active surveillance in the management of men with localized prostate cancer.

Ganz PA, Barry JM, Burke W, Col NF, Corso PS, Dodson E, Hammond ME, Kogan BA, Lynch CF, Newcomer L, Seifter EJ, Tooze JA, Viswanath K, Wessells H.

Ann Intern Med. 2012 Apr 17;156(8):591-5. doi: 10.7326/0003-4819-156-8-201204170-00401. Epub 2012 Feb 20. No abstract available.

10.

Active surveillance of prostate cancer in African American men.

Silberstein JL, Feibus AH, Maddox MM, Abdel-Mageed AB, Moparty K, Thomas R, Sartor O.

Urology. 2014 Dec;84(6):1255-61. doi: 10.1016/j.urology.2014.06.064. Epub 2014 Oct 3. Review.

PMID:
25283702
11.
12.

Predictive Factors for Reclassification and Relapse in Prostate Cancer Eligible for Active Surveillance: A Systematic Review and Meta-analysis.

Petrelli F, Vavassori I, Cabiddu M, Coinu A, Ghilardi M, Borgonovo K, Lonati V, Barni S.

Urology. 2016 May;91:136-42. doi: 10.1016/j.urology.2016.01.034. Epub 2016 Feb 16. Review.

PMID:
26896733
13.

Management of low risk prostate cancer: active surveillance and focal therapy.

Klotz L, Emberton M.

Curr Opin Urol. 2014 May;24(3):270-9. doi: 10.1097/MOU.0000000000000055. Review.

PMID:
24710055
14.

Active surveillance in prostate cancer: the need to standardize.

Filella X, Alcover J, Molina R.

Tumour Biol. 2011 Oct;32(5):839-43. doi: 10.1007/s13277-011-0193-2. Epub 2011 May 28. Review.

PMID:
21625940
15.

Active surveillance in prostate cancer: a critical review.

Zargar H, Giannarini G, Loeb S, Dasgupta P, Murphy DG, Ficarra V.

Minerva Urol Nefrol. 2015 Sep;67(3):247-61. Epub 2015 Jun 9. Review.

PMID:
26054412
16.

The Prostate Health Index: Its Utility in Prostate Cancer Detection.

Lepor A, Catalona WJ, Loeb S.

Urol Clin North Am. 2016 Feb;43(1):1-6. doi: 10.1016/j.ucl.2015.08.001. Review.

17.

Contemporary issues in the diagnosis of prostate cancer for the radiologist.

Clements R.

Eur Radiol. 2006 Jul;16(7):1580-90. Epub 2006 Apr 1. Review.

PMID:
16583213
18.

Active surveillance in prostate cancer: patient selection and triggers for intervention.

Lees K, Durve M, Parker C.

Curr Opin Urol. 2012 May;22(3):210-5. doi: 10.1097/MOU.0b013e328351dc47. Review.

PMID:
22388664
19.

The Emerging Role of MRI in Prostate Cancer Active Surveillance and Ongoing Challenges.

Barrett T, Haider MA.

AJR Am J Roentgenol. 2017 Jan;208(1):131-139. doi: 10.2214/AJR.16.16355. Epub 2016 Oct 11. Review.

PMID:
27726415
20.

Current Management Strategy for Active Surveillance in Prostate Cancer.

Syed JS, Javier-Desloges J, Tatzel S, Bhagat A, Nguyen KA, Hwang K, Kim S, Sprenkle PC.

Curr Oncol Rep. 2017 Feb;19(2):11. doi: 10.1007/s11912-017-0569-6. Review.

PMID:
28220449

Supplemental Content

Support Center